Kymera Therapeutics Inc —— 季度财务数据 (NASDAQ:KYMR) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -61.78 M-79.15 M-59.88 M-27.11 M-66.75 M -232.89 M 投资活动产生的现金 68.57 M48.62 M60.02 M-235.3 M-394.4 M -521.06 M 融资活动产生的现金 2.77 M258 K245.73 M39.51 M705.22 M 990.71 M 自由现金流 -62.72 M-79.62 M-60.58 M-27.29 M-66.85 M -234.34 M

新闻

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Kymera在Leerink全球医疗保健会议上的战略见解:药物开发进展

Kymera at Leerink Global Healthcare: Strategic Insights on Drug Development

Kymera将在AAD会议上公布特应性皮炎试验数据

Kymera to present atopic dermatitis trial data at AAD meeting

Kymera at TD Cowen Conference: Strategic Insights on Drug Programs

Stephens raises Kymera Therapeutics price target to $100 on pipeline

Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway

摩根士丹利下调Kymera Therapeutics目标价,关注管线进展

Morgan Stanley cuts Kymera Therapeutics stock price target on pipeline progress